Irinotecan and 5-fluorouracil in colorectal cancer: Time for a pause?

被引：5
|
作者：
Bulusu, VR [1 ]
机构：
[1] Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 2QQ, England
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷 / 03期
关键词：
D O I：
10.1016/S0959-8049(97)10064-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：286 / 289
页数：4
相关论文
共 50 条
  • [21] Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer -: A feasibility pilot study
    Calvo, E
    Cortés, J
    González-Cao, M
    Rodríguez, J
    Aramendía, JM
    Fernández-Hidalgo, O
    Martín-Algarra, S
    Salgado, JE
    Martínez-Monge, R
    de Irala, J
    Brugarolas, A
    ONCOLOGY, 2002, 63 (03) : 254 - 265
  • [22] Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer
    Berlin, Jordan
    Posey, James
    Tchekmedyian, Simon
    Hu, Eddie
    Chan, David
    Malik, Imtiaz
    Yang, Liqiang
    Amado, Rafael G.
    Hecht, J. Randolph
    CLINICAL COLORECTAL CANCER, 2007, 6 (06) : 427 - 432
  • [23] Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer
    Kono, T
    Ebisawa, Y
    Tomita, I
    Chisato, N
    Kamiya, K
    Asama, T
    Ayabe, T
    Ashida, T
    Kohgo, Y
    Kasai, S
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 224 - 227
  • [24] Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil
    Pfeiffer, Per
    Nielsen, Dorte
    Yilmaz, Mette
    Iversen, Anja
    Vejlo, Christian
    Jensen, Benny Vittrup
    ACTA ONCOLOGICA, 2007, 46 (05) : 697 - 701
  • [25] Health-Related Quality of Life Impact of Bevacizumab When Combined with Irinotecan, 5-Fluorouracil, and Leucovorin or 5-Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
    Kabbinavar, Fairooz F.
    Wallace, Joel F.
    Holmgren, Eric
    Yi, Jing
    Cella, David
    Yost, Kathleen J.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2008, 13 (09): : 1021 - 1029
  • [26] Clinical colorectal cancer: "Ode to 5-Fluorouracil"
    Chu, Edward
    CLINICAL COLORECTAL CANCER, 2007, 6 (09) : 609 - 609
  • [27] Panitumumab therapy with irinotecan, 5-fluorouracil, and leucovorin (IFL) in patients (pts) with metastatic colorectal cancer (mCRC)
    Berlin, Jordan
    Malik, Imtiaz
    Picus, Joel
    Glisson, Shawn
    Kozloff, Mark
    Spitzer, Gary
    Wiens, Brian
    MacDonald, Monica
    Jerian, Susan
    Hecht, J. Randolph
    ANNALS OF ONCOLOGY, 2004, 15 : 70 - 71
  • [28] Irinotecan combined with bolus 5-fluorouracil and folinic acid for metastatic colorectal cancer: Is this really a dangerous treatment?
    Idelevich, E
    Man, S
    Lavrenkov, K
    Gluzman, A
    Geffen, DB
    Shani, A
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (05) : 487 - 490
  • [29] Combination of irinotecan, oxaliplatin and 5-fluorouracil as a rechallenge regimen for heavily pretreated metastatic colorectal cancer patients
    Fernandes G.D.S.
    Braghiroli M.I.
    Artioli M.
    Paterlini A.C.C.R.
    Teixeira M.C.
    Gumz B.P.
    Girardi D.M.
    Braghiroli O.F.M.
    Costa F.P.
    Hoff P.M.
    Journal of Gastrointestinal Cancer, 2018, 49 (4) : 470 - 475
  • [30] Radiosensitizing Effects of Irinotecan versus Oxaliplatin Alone and in Combination with 5-Fluorouracil on Human Colorectal Cancer Cells
    Frerker, Bernd
    Bock, Felix
    Cappel, Marie-Louise
    Kriesen, Stephan
    Klautke, Gunther
    Hildebrandt, Guido
    Manda, Katrin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
12345